Home
>
National Drug Code (NDC)
>
Theophylline Extended Release
Theophylline Extended Release - 0615-2503-39 - (Theophylline, anhydrous)
Drug Information of Theophylline Extended Release
| Product NDC: | 0615-2503 |
| Proprietary Name: | Theophylline Extended Release |
| Non Proprietary Name: | Theophylline, anhydrous |
| Active Ingredient(s): | 200 mg/1 & nbsp; Theophylline, anhydrous |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Theophylline Extended Release
| Product NDC: | 0615-2503 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089808 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19900430 |
Package Information of Theophylline Extended Release
| Package NDC: | 0615-2503-39 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-2503-39) |
NDC Information of Theophylline Extended Release
| NDC Code | 0615-2503-39 |
| Proprietary Name | Theophylline Extended Release |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-2503-39) |
| Product NDC | 0615-2503 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Theophylline, anhydrous |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19900430 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | THEOPHYLLINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
